Dr. Ahmad M. Abu-Ghaida, MD

Dr. Abu-Ghaida practices at Fresenius Kidney Care Franklin Square Home in Baltimore, Maryland.

Dr. Abu-Ghaida's NPI, 1659320257, was assigned on May 9, 2006. Dr. Abu-Ghaida graduated from University of Jordan Faculty of Medicine in 1985. Dr. Abu-Ghaida holds Maryland license D0057613.

Dr. Abu-Ghaida's primary practice is Fresenius Kidney Care Franklin Square Home, at 5233 King Avenue Suite 116, Baltimore, MD 21237 in Baltimore County. The practice phone is (410) 391-5836.

Dr. Abu-Ghaida's primary practice is Fresenius Kidney Care Franklin Square Home in Baltimore, Maryland. Dr. Abu-Ghaida is also affiliated with MedStar Franklin Square Medical Center. The medical group on file is White Square Vascular Surgery. Dmand AI also links Dr. Abu-Ghaida to 1 more group practice or clinic, named with a free account. Dr. Abu-Ghaida's employer is on file too: a dialysis center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abu-Ghaida practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Abu-Ghaida's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Abu-Ghaida is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Abu-Ghaida's licenses on file in 4 states: Maryland, New York, Ohio and New Jersey.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Abu-Ghaida treats.

CMS data shows 55,471 Medicare services from Dr. Abu-Ghaida across 41 procedure codes in 2024, for 1,363 Medicare patients. Medicare paid $3,088,251 for them.

CMS counts 1,363 Medicare patients who saw Dr. Abu-Ghaida in 2024. The largest group is 65 to 74, with 533 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abu-Ghaida's median patient age at 74, with 52% women.

In 2024, Dr. Abu-Ghaida wrote 878 Medicare Part D claims for 296 patients. 89% of them were for generic drugs. CMS names the drug for 823 of them, across 6 drugs with 11 or more claims each, at $84,930 in total drug cost. In 2023, CMS named 661 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Abu-Ghaida for performance year 2024, reported as part of a group. Dr. Abu-Ghaida accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 220 procedures of leg revascularization (restoring blood flow) by Dr. Abu-Ghaida, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Abu-Ghaida.

CMS Open Payments shows 148 general payments to Dr. Abu-Ghaida from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Medtronic Vascular, Inc. paid the most, $3,153.

Dmand AI lists 1 award for Dr. Abu-Ghaida.

Dr. Abu-Ghaida graduated from University of Jordan Faculty of Medicine in 1985. Dr. Abu-Ghaida is a member of ACS and SVS.

Dr. Abu-Ghaida is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.